1. CDK10 in Gastrointestinal Cancers: Dual Roles as a Tumor Suppressor and Oncogene
   Zainab A. Bazzi et al, 2021, Frontiers in Oncology CrossRef
2. Aberrant expression of CDK8 regulates the malignant phenotype and associated with poor prognosis in human laryngeal squamous cell carcinoma
   MingHua Li et al, 2017, European Archives of Oto-Rhino-Laryngology CrossRef
3. Comprehensive analysis of the transcriptional profile of the Mediator complex across human cancer types
   Isabella Syring et al, 2016, Oncotarget CrossRef
4. 2,8-Disubstituted-1,6-Naphthyridines and 4,6-Disubstituted-Isoquinolines with Potent, Selective Affinity for CDK8/19
   Aurélie Mallinger et al, 2016, ACS Medicinal Chemistry Letters CrossRef
5. A Selective and Orally Bioavailable Quinoline-6-Carbonitrile-Based Inhibitor of CDK8/19 Mediator Kinase with Tumor-Enriched Pharmacokinetics
   Li Zhang et al, 2022, Journal of Medicinal Chemistry CrossRef
6. Structure-Based Optimization of Potent, Selective, and Orally Bioavailable CDK8 Inhibitors Discovered by High-Throughput Screening
   Paul Czodrowski et al, 2016, Journal of Medicinal Chemistry CrossRef
7. Retroviral Cyclin Controls Cyclin-Dependent Kinase 8-Mediated Transcription Elongation and Reinitiation
   Claire H. Birkenheuer et al, 2015, Journal of Virology CrossRef
8. Discovery of Potent, Selective, and Orally Bioavailable Small-Molecule Modulators of the Mediator Complex-Associated Kinases CDK8 and CDK19
   Aurélie Mallinger et al, 2016, Journal of Medicinal Chemistry CrossRef
9. Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review
   Miguel Angel Chiurillo, 2015, World Journal of Experimental Medicine CrossRef
10. TMIGD1 acts as a tumor suppressor through regulation of p21Cip1/p27Kip1 in renal cancer
    Rosana D. Meyer et al, 2018, Oncotarget CrossRef
11. Discovery of LL-K8-22: A Selective, Durable, and Small-Molecule Degrader of the CDK8-Cyclin C Complex
    Mingyu Wang et al, 2023, Journal of Medicinal Chemistry CrossRef
12. Discovery of the Novel 1H-Pyrrolo[2,3-b]pyridine Derivative as a Potent Type II CDK8 Inhibitor against Colorectal Cancer
    Xing Xing Zhang et al, 2022, Journal of Medicinal Chemistry CrossRef
13. Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities
    Mitra Zabihi et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef